Loading insider details...
Beta
Latest Form 4 (May 20, 2026): Purchase of 5,000 CRVS shares, $60.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 20, 2026 | Corvus Pharmaceuticals, Inc. (CRVS) | Purchase | 5,000 | $60.3K |
| Dec 8, 2025 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 1,000,000 | n/a |
| May 9, 2025 | Corvus Pharmaceuticals, Inc. (CRVS) | Exercise/Conversion | 559,073 | $1.96M |
| Dec 23, 2024 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 750,000 | n/a |
| May 14, 2024 | Corvus Pharmaceuticals, Inc. (CRVS) | Gift | 302,016 | n/a |
| May 7, 2024 | Corvus Pharmaceuticals, Inc. (CRVS) | Purchase | 577,634 | $1000.0K |
| Dec 8, 2023 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 500,000 | n/a |
| Jun 14, 2023 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/Award | 25,000 | n/a |
| Apr 3, 2023 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 800,000 | n/a |
| Dec 16, 2022 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/Award | 25,000 | n/a |